Danesh Alam
Psychiatry · Winfield, ILNPI 1043227200
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,409 of the $37,582 with a category attached, or 88.9%. 8 manufacturers reported payments, led by Johnson & Johnson at 34.9% of the total. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $916.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$13K
- Eli Lilly$11K
- Alkermes, Inc.$8K
- MDD US Operations, LLC$5K
- Livanova USA, Inc.$500
- E.r. Squibb & Sons, L.L.C.$51
- plus $56 from 2 others
Across 454 payments — averaging $5769.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$582K
- Indivior Inc.$563K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$517K
- Janssen Research & Development, LLC$449K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$374K
- Acadia Pharmaceuticals Inc$79K
- plus $54K from 5 others
What the payments were for
- Consulting fees$33,40989%
- Travel & lodging$2,8177%
- Food & beverage$1,3554%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 20 | $13,111 |
| Eli Lilly | 1 | $11,219 |
| Alkermes, Inc. | 1 | $7,500 |
| MDD US Operations, LLC | 11 | $5,145 |
| Livanova USA, Inc. | 4 | $500 |
| E.r. Squibb & Sons, L.L.C. | 2 | $51 |
| Indivior Inc. | 1 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$12,840
- VIVITROL$7,500
- Lucemyra/Lofexidine$4,969
- VNS Therapy$316
How this compares
$37,582 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $3,291 |
| Trazodone Hcl | 21 | $347 |
| Fluoxetine Hcl | 17 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Suboxone | $37 | $3,29112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Winfield
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Mark ShukhmanSkokie$250K
- Abid NazeerOak Brook$228K
- Nitin ThaparOrland Park$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.